5 inequalities, 5 solutions

We have launched a new report – called Men United v Prostate Cancer: Five inequalities, five solutions - and are asking for MPs’ support to help us tackle the lack of awareness about prostate cancer, the variation in care and treatment that men get, and the differences in experience for older men and Black men.

It would be fantastic if you could help ensure your MP gets a copy of the report so they can learn about these important issues. They have the power to help us change things.



Print thisPrint Button

Why do we campaign?

We want services and care for men with prostate cancer to be the very best, so we campaign alongside our supporters for improvements. We collect evidence for our campaigns, and make sure we target the key decision-makers to get the change we want to see. We need your help. Please sign up to receive our newsletter to find out how you can get involved.

Our current campaigns

  • Abiraterone pre-chemotherapy

    Abiraterone, a drug which could delay the need for men with advanced prostate cancer to have chemotherapy, has been rejected by the National Institute for Health and Care Excellence (NICE).

    Find out more
  • 5 inequalities, 5 solutions

    Help us tackle the inequalities that men with prostate cancer experience

    Find out more
  • Enzalutamide

    Men with prostate cancer should be able to have any treatment that their doctor recommends for them. Tell us if NICE's decision about enzalutamide affects you.

    Find out more
  • A quality checklist: Your standards of care

    We've launched our Quality Checklist to help make quality care a reality for all men with prostate cancer.

    Find out more
  • Value-based assessment

    From 2014 all new branded drugs will be subject to a different process of drug pricing known as value-based assessment. We are working with other cancer charities to ensure the views of people affected by cancer are put at the heart of the new policy.

    Find out more

Our past campaigns

We closed our Testing Choices campaign in 2013. Find out more.